BACKGROUND: Multiple myeloma (MM) is a cancer of terminally differentiated plasma that is part of a spectrum of blood diseases. The role of the micro-environment is crucial for MM clonal evolution. METHODS: This paper describes the analysis carried out on a limited number of genes automatically extracted by a nonnegative matrix factorization (NMF) based approach from gene expression profiles of bone marrow fibroblasts of patients with monoclonal gammopathy of undetermined significance (MGUS) and MM. RESULTS: Automatic exploration through NMF, combined with a motivated post-processing procedure and a pathways analysis of extracted genes, allowed to infer that a functional switch is required to lead fibroblasts to acquire pro-tumorig...
Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM), 5 with m...
SummaryTo identify genetic events underlying the genesis and progression of multiple myeloma (MM), w...
OBJECTIVE: Multiple myeloma (MM) is characterized by a high incidence of osteolytic bone lesions,...
BACKGROUND: Multiple myeloma (MM) is a cancer of terminally differentiated plasma that is part of a...
Additional file 1: Tables S1 and S2. Genes and their corresponding median value of MGUS and MM
Background: Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells i...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
ABSTRACT: BACKGROUND: Multiple myeloma (MM) is characterized by a strong dependence of the tumor cel...
International audienceBACKGROUND: Multiple myeloma (MM) is characterized by a strong dependence of t...
The rapid development of high-performance technologies has greatly promoted studies of molecular onc...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
Multiple myeloma (MM) is a genetically complex disease that results from a multistep transformation ...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
PURPOSE:The combined use of microarray technologies and bioinformatics analysis has improved our und...
Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM), 5 with m...
SummaryTo identify genetic events underlying the genesis and progression of multiple myeloma (MM), w...
OBJECTIVE: Multiple myeloma (MM) is characterized by a high incidence of osteolytic bone lesions,...
BACKGROUND: Multiple myeloma (MM) is a cancer of terminally differentiated plasma that is part of a...
Additional file 1: Tables S1 and S2. Genes and their corresponding median value of MGUS and MM
Background: Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells i...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
ABSTRACT: BACKGROUND: Multiple myeloma (MM) is characterized by a strong dependence of the tumor cel...
International audienceBACKGROUND: Multiple myeloma (MM) is characterized by a strong dependence of t...
The rapid development of high-performance technologies has greatly promoted studies of molecular onc...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
Multiple myeloma (MM) is a genetically complex disease that results from a multistep transformation ...
Multiple myeloma (MM) has two clinical precursor stages of disease: monoclonal gammopathy of undeter...
PURPOSE:The combined use of microarray technologies and bioinformatics analysis has improved our und...
Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM), 5 with m...
SummaryTo identify genetic events underlying the genesis and progression of multiple myeloma (MM), w...
OBJECTIVE: Multiple myeloma (MM) is characterized by a high incidence of osteolytic bone lesions,...